HB 2434
In CommitteeHouse
Rabies medication
Ensuring the availability of rabies medication for postexposure prophylaxis.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires all hospitals with emergency departments in Washington to keep rabies medication on hand so they can give the first dose of treatment right away to people exposed to rabies. It also requires them to ensure the rest of the treatment series can be completed in a timely way.
- Starting January 1, 2027, every hospital with an emergency department must keep a supply of rabies postexposure prophylaxis (PEP) medication on hand to give a first dose immediately upon arrival.
- Hospitals must ensure the full course of rabies treatment (typically 4–5 doses over 14–28 days) can be completed, either by keeping extra doses on-site or by arranging timely delivery from another source.
- The law applies only when medically indicated — meaning a doctor determines the patient needs the medication based on exposure risk.
- The bill adds a new section to chapter 70.41 RCW, the state’s public health code, to formalize this requirement.
Who is affected
- People exposed to potentially rabid animals — People who are exposed to animals suspected or known to have rabies (e.g., through bites or scratches) may receive immediate rabies treatment at any hospital with an emergency department, reducing delays in care.
- Hospitals with emergency departments — Must ensure they have access to full rabies treatment series, either by keeping medication on-site or arranging timely delivery from another source.
- Rural and underserved communities — May benefit from faster access to life-saving treatment, especially in rural or underserved areas where specialized medications are not always available.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (3)
Immediate access to first-dose rabies PEP at any emergency department reduces delays in life-saving treatment, which is critical because rabies is nearly 100% fatal once symptoms appear—this directly benefits patients across all income levels who suffer animal exposures.
HealthcarePeopleRef: Sec. 1, new RCW under ch. 70.41Standardizing rabies PEP availability across all emergency departments improves regional public health preparedness and reduces disparities in access, especially for people in rural or underserved areas who previously may have had to travel long distances for treatment.
Public SafetyPeopleRef: Sec. 1, new RCW under ch. 70.41The requirement that treatment be provided only when “medically indicated” (i.e., physician-determined exposure risk) prevents unnecessary use and helps control costs, balancing clinical appropriateness with system burden.
HealthcarePeopleRef: Sec. 1, new RCW under ch. 70.41
Potential Concerns (1)
Hospitals—especially small, rural, or safety-net facilities—may face significant operational and financial burdens to maintain rabies PEP on-site or coordinate timely off-site delivery, potentially diverting resources from other urgent care needs.
HealthcarePeopleRef: Sec. 1, new RCW under ch. 70.41
Who Is Most Affected
Patients exposed to rabid animals—especially those in rural areas or without private insurance—gain guaranteed, immediate access to life-saving treatment at any emergency department, reducing delays and preventing fatal outcomes.
Hospitals with emergency departments must incur new costs (procurement, storage, logistics) to comply; small or rural hospitals may face disproportionate strain due to lower patient volumes and limited economies of scale.
Rural and underserved communities benefit most from this standardization, as they often lack access to specialized medications and may previously have faced transport delays or treatment denials.